Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Venu M Ganipisetti

Presbyterian Hospital, Albuquerque
USA
Publications

A Search for the Risk Factors for Daptomycin-Rifampin-Induced Rhabdomyolysis, Liver Injury and Acute Kidney Injury

The Infectious Diseases Society of America recommends daptomycin as one of the antibiotics for treating Methicillin-Resistant Staphylococcus aureus (MRSA) bone and joint infections and native valve infective endocarditis. The addition of rifampin may be particularly beneficial in cases of prosthetic joint infections due to rifampin's biofilm-disrup... Read More»

Venu M Ganipisetti and Anand Athavale

: J Infect Dis Ther

10.4172/2332-0877.1000537

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top